| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1469-0691.2010.03236.X |
| P953 | full work available at URL | http://www.clinicalmicrobiologyandinfection.com/article/S1198743X14617341/pdf |
| https://api.elsevier.com/content/article/PII:S1198743X14617341?httpAccept=text/xml | ||
| https://api.elsevier.com/content/article/PII:S1198743X14617341?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 20880410 |
| P5875 | ResearchGate publication ID | 46819734 |
| P50 | author | Fadi Bittar | Q49360813 |
| Jean-Marc Rolain | Q34572450 | ||
| P2860 | cites work | Chronic colonization with Pandoraea apista in cystic fibrosis patients determined by repetitive-element-sequence PCR. | Q24544090 |
| Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis | Q24550797 | ||
| Inquilinus limosus in patients with cystic fibrosis, Germany | Q24620282 | ||
| Complex molecular epidemiology of methicillin-resistant staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus | Q45411110 | ||
| Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing | Q45772438 | ||
| Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. | Q46002328 | ||
| Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients | Q46131950 | ||
| Isolation of Nocardia species in patients with cystic fibrosis | Q46686312 | ||
| Increased mutability of Pseudomonas aeruginosa in biofilms | Q46767850 | ||
| Use of 16S rRNA gene sequencing for identification of "Pseudomonas-like" isolates from sputum of patients with cystic fibrosis | Q48126949 | ||
| Use of the gyrB gene for the identification of Pandoraea species | Q48309987 | ||
| Molecular typing of the bacterial flora in sputum of cystic fibrosis patients. | Q51653034 | ||
| Nocardia asteroides isolated from three patients with cystic fibrosis. | Q51720403 | ||
| The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa. | Q53618798 | ||
| Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. | Q53852065 | ||
| [Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients] | Q53919111 | ||
| Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. | Q54182171 | ||
| RISA-HPLC analysis of lung bacterial colonizers of cystic fibrosis children. | Q54511897 | ||
| Clonal analysis of Inquilinus limosus isolates from six cystic fibrosis patients and specific serum antibody response. | Q54579124 | ||
| Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis | Q57913654 | ||
| Transcriptome analyses and biofilm-forming characteristics of a clonal Pseudomonas aeruginosa from the cystic fibrosis lung | Q58056362 | ||
| First report of Paenibacillus cineris from a patient with cystic fibrosis | Q60454002 | ||
| Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis | Q74422423 | ||
| Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis | Q80832892 | ||
| A 10-year large-scale cystic fibrosis carrier screening in the Italian population | Q84865297 | ||
| A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients | Q24652357 | ||
| Bacterial activity in cystic fibrosis lung infections | Q24813737 | ||
| Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide | Q24816990 | ||
| Cystic fibrosis | Q28212180 | ||
| Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa | Q28492507 | ||
| Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions | Q28492782 | ||
| Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
| Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry | Q29616600 | ||
| Lung infections associated with cystic fibrosis | Q30080000 | ||
| Bacterial strain typing in the genomic era. | Q30377265 | ||
| Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov | Q30695296 | ||
| Advenella incenata gen. nov., sp. nov., a novel member of the Alcaligenaceae, isolated from various clinical samples | Q30980585 | ||
| Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. | Q31030261 | ||
| Emerging and unusual gram-negative infections in cystic fibrosis | Q31115361 | ||
| First isolations of Segniliparus rugosus from patients with cystic fibrosis | Q31120557 | ||
| Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis | Q33310144 | ||
| Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex | Q33351831 | ||
| Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients | Q33358120 | ||
| Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients | Q33358344 | ||
| Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum | Q33370443 | ||
| Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections | Q33379091 | ||
| Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. | Q33397958 | ||
| Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients | Q33413056 | ||
| Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches | Q33430526 | ||
| Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry | Q33454687 | ||
| Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals | Q33509530 | ||
| Pseudomonas aeruginosa regulates flagellin expression as part of a global response to airway fluid from cystic fibrosis patients | Q33696479 | ||
| Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture | Q33699922 | ||
| PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients | Q33715997 | ||
| Pathogenicity of microbes associated with cystic fibrosis | Q33807320 | ||
| Metagenomic pyrosequencing and microbial identification | Q33944054 | ||
| Capillary electrophoresis-single-strand conformation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis | Q33963123 | ||
| Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. | Q34041641 | ||
| Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence | Q34151362 | ||
| Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation. | Q34197176 | ||
| Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. | Q34232085 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients | Q34956792 | ||
| Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa | Q35168460 | ||
| Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients | Q35196529 | ||
| Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis | Q35213050 | ||
| Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis | Q35535652 | ||
| Infection control in cystic fibrosis | Q35545544 | ||
| Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. | Q35638889 | ||
| In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients | Q36313798 | ||
| Isolation of Lautropia mirabilis from sputa of a cystic fibrosis patient | Q36544181 | ||
| Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients | Q36708763 | ||
| Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients | Q36845344 | ||
| 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls | Q36878347 | ||
| Cystic fibrosis: a polymicrobial infectious disease | Q36895733 | ||
| Misidentification of Pandoraea sputorum isolated from sputum of a patient with cystic fibrosis and review of Pandoraea species infections in transplant patients | Q36898168 | ||
| Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel | Q36944748 | ||
| The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients | Q37033480 | ||
| Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology | Q37064461 | ||
| Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage | Q37069059 | ||
| Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing | Q37104903 | ||
| Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. | Q37119379 | ||
| The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review | Q37126198 | ||
| characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling | Q37597340 | ||
| Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment | Q37703045 | ||
| Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients | Q38476154 | ||
| Identification of members of the Burkholderia cepacia complex by species-specific PCR. | Q39460070 | ||
| Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays | Q39467342 | ||
| Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis | Q39467759 | ||
| Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. | Q39665032 | ||
| Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients | Q39697563 | ||
| Microarray analysis of global gene expression in mucoid Pseudomonas aeruginosa | Q39705810 | ||
| Evaluation of MicroScan Autoscan for identification of Pseudomonas aeruginosa isolates from cystic fibrosis patients | Q39732748 | ||
| Use of real-time PCR with multiple targets to identify Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli from patients with cystic fibrosis | Q39887228 | ||
| Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium | Q40013162 | ||
| Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. | Q40014245 | ||
| In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells | Q40021908 | ||
| Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. | Q40340234 | ||
| Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. | Q41091925 | ||
| Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. | Q41481789 | ||
| Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis | Q41819863 | ||
| First isolation of two colistin-resistant emerging pathogens, Brevundimonas diminuta and Ochrobactrum anthropi, in a woman with cystic fibrosis: a case report | Q41896105 | ||
| EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates | Q41908042 | ||
| Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis | Q41909591 | ||
| Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis | Q41960504 | ||
| Recovery of Herbaspirillum species from persons with cystic fibrosis | Q41986091 | ||
| Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples. | Q42286592 | ||
| Identification of isolates within the Burkholderia cepacia complex by a multiplex recA and 16S rRNA gene real-time PCR assay | Q42909885 | ||
| Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction | Q43065927 | ||
| Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus | Q43181776 | ||
| Inquilinus limosus and cystic fibrosis | Q43230341 | ||
| Acetobacter indonesiensis pneumonia after lung transplant | Q43230349 | ||
| Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients | Q43447859 | ||
| RecA gene sequence and Multilocus Sequence Typing for species-level resolution of Burkholderia cepacia complex isolates | Q43481176 | ||
| Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes | Q44190265 | ||
| Nocardia farcinica isolated from bronchoalveolar lavage fluid of a child with cystic fibrosis | Q44290021 | ||
| Chryseobacterium respiratory tract infections in patients with cystic fibrosis | Q44851340 | ||
| Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates | Q45129729 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 809-820 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Clinical Microbiology and Infection | Q15757285 |
| P1476 | title | Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients | |
| P478 | volume | 16 |
| Q35897260 | A Novel Depsipeptide Produced by Paenibacillus alvei 32 Isolated from a Cystic fibrosis Patient |
| Q55040599 | A practical molecular identification of nonfermenting Gram-negative bacteria from cystic fibrosis. |
| Q34916610 | Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period |
| Q38546468 | Animal models of polymicrobial pneumonia |
| Q35127881 | Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods |
| Q26799417 | Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status |
| Q37911731 | Bacteriophages as vehicles of the resistome in cystic fibrosis. |
| Q30388877 | Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function |
| Q34536205 | Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis |
| Q34101572 | Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry |
| Q85110286 | Cystic fibrosis: deciphering the complexity |
| Q46495945 | Discriminating typical and atypical cystic fibrosis-related bacteria by multiplex PNA-FISH. |
| Q42268855 | Genome sequence of Microbacterium yannicii, a bacterium isolated from a cystic fibrosis patient |
| Q35074619 | High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment |
| Q34706914 | Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations |
| Q38992886 | Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use Antibiotics |
| Q46277042 | Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum |
| Q43018827 | Lung biopsies for interstitial lung disease: the limits of the traditional methods of microbiological identification |
| Q35922452 | Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity |
| Q35124580 | Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy. |
| Q31152913 | Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencing |
| Q34982856 | Modern clinical microbiology: new challenges and solutions |
| Q38080967 | Molecular detection of CF lung pathogens: current status and future potential |
| Q41684286 | Pandoraea pulmonicola chronic colonization in a cystic fibrosis patient, France |
| Q34705295 | Phenotypic and genotypic properties of Microbacterium yannicii, a recently described multidrug resistant bacterium isolated from a lung transplanted patient with cystic fibrosis in France |
| Q40043995 | Phylogenetic Analysis and Antimicrobial Profiles of Cultured Emerging Opportunistic Pathogens (Phyla Actinobacteria and Proteobacteria) Identified in Hot Springs. |
| Q35905382 | Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis |
| Q36152854 | Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability |
| Q36063996 | Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline |
| Q55444974 | Quantitative assessment of individual populations within polymicrobial biofilms. |
| Q55664083 | Rapid detection of four non-fermenting Gram-negative bacteria directly from cystic fibrosis patient's respiratory samples on the BD MAX™ system. |
| Q41822066 | Rapid identification of Stenotrophomonas maltophilia by peptide nucleic acid fluorescence in situ hybridization |
| Q33770039 | Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens |
| Q35861377 | The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy |
Search more.